Cargando…
Safety and efficacy of intrathecal ziconotide in the management of severe chronic pain
Ziconotide is a conopeptide intrathecal (IT) analgesic which is approved by the US Food and Drug Administration (FDA) for the management of severe chronic pain. It is a synthetic equivalent of a naturally occurring conopeptide found in the venom of the fish-eating marine cone snail and provides anal...
Autores principales: | Smith, Howard S, Deer, Timothy R |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2710384/ https://www.ncbi.nlm.nih.gov/pubmed/19707262 |
Ejemplares similares
-
Intrathecal Therapy for Chronic Pain: A Review of Morphine and Ziconotide as Firstline Options
por: Deer, Timothy R, et al.
Publicado: (2019) -
Intrathecal pain management with ziconotide: Time for consensus?
por: Matis, Georgios, et al.
Publicado: (2021) -
Intrathecal Ziconotide: Dosing and Administration Strategies in Patients With Refractory Chronic Pain
por: McDowell, Gladstone C., et al.
Publicado: (2016) -
Intrathecal Administration of Ziconotide as a Potential Treatment for Chronic Migraines
por: Holden, Ryan, et al.
Publicado: (2022) -
Resolution of chronic migraine headaches with intrathecal ziconotide: a case report
por: Narain, Sachin, et al.
Publicado: (2015)